These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 33715138)

  • 41. Patient access to chronic medications during the Covid-19 pandemic: Evidence from a comprehensive dataset of US insurance claims.
    Clement J; Jacobi M; Greenwood BN
    PLoS One; 2021; 16(4):e0249453. PubMed ID: 33793663
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antidepressants, primary care, and adult mental health services in England during COVID-19.
    Armitage R
    Lancet Psychiatry; 2021 Feb; 8(2):e3. PubMed ID: 33485423
    [No Abstract]   [Full Text] [Related]  

  • 43. Trends in antidepressant prescribing to children and adolescents in Canadian primary care: A time-series analysis.
    Morkem R; Williamson T; Patten S; Queenan JA; Wong ST; Manca D; Barber D
    Pharmacoepidemiol Drug Saf; 2017 Sep; 26(9):1093-1099. PubMed ID: 28594077
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Economic costs of antidepressant use: a population-based study in Sweden.
    Beckman L; von Kobyletzki L; Svensson M
    J Ment Health Policy Econ; 2019 Dec; 22(4):125-130. PubMed ID: 32058977
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Potential savings from splitting newer antidepressant medications.
    Cohen CI; Cohen SI
    CNS Drugs; 2002; 16(5):353-8. PubMed ID: 11994024
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Who bears the costs of antidepressants in Australia?
    Gorham PN
    Med J Aust; 1995 Feb; 162(3):162-3; author reply 164. PubMed ID: 7854234
    [No Abstract]   [Full Text] [Related]  

  • 47. The EU referendum and mental health in the short term: a natural experiment using antidepressant prescriptions in England.
    Vandoros S; Avendano M; Kawachi I
    J Epidemiol Community Health; 2019 Feb; 73(2):168-175. PubMed ID: 30464033
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Forecasting the future burden of opioids for osteoarthritis.
    Ackerman IN; Zomer E; Gilmartin-Thomas JF; Liew D
    Osteoarthritis Cartilage; 2018 Mar; 26(3):350-355. PubMed ID: 29129650
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Who bears the costs of antidepressants in Australia?
    Haski RR; Grainger D
    Med J Aust; 1995 Feb; 162(3):164. PubMed ID: 7854236
    [No Abstract]   [Full Text] [Related]  

  • 50. Are drugs a cost or an investment?
    Goetzel RZ; Ozminkowski RJ; Del Rosso G; Schutt DC
    Bus Health; 2000 Jun; 18(6):39-42, 45. PubMed ID: 11067243
    [No Abstract]   [Full Text] [Related]  

  • 51. The pattern of prescribing of glucose modulating agents for type 2 diabetes in general practices in England 2016/17.
    Heald AH; Livingston M; Bien Z; Moreno GYC; Laing I; Stedman M
    Int J Clin Pract; 2018 Apr; 72(4):e13080. PubMed ID: 29537664
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 10-year trends in English primary care glaucoma prescribing.
    Hogg HDJ; Connor A
    Eye (Lond); 2020 Jan; 34(1):192-196. PubMed ID: 31685974
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Do doctors in dispensing practices with a financial conflict of interest prescribe more expensive drugs? A cross-sectional analysis of English primary care prescribing data.
    Goldacre B; Reynolds C; Powell-Smith A; Walker AJ; Yates TA; Croker R; Smeeth L
    BMJ Open; 2019 Feb; 9(2):e026886. PubMed ID: 30813120
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Meta-analysis of antidepressant prescribing. Drop out rates presented in a misleading manner.
    Freemantle N; Mason J
    BMJ; 1995 Sep; 311(7007):751. PubMed ID: 7549711
    [No Abstract]   [Full Text] [Related]  

  • 55. [Recurrence of depression caused by pharmacies].
    Brødsgaard M
    Ugeskr Laeger; 2001 Aug; 163(34):4602-4. PubMed ID: 11530576
    [No Abstract]   [Full Text] [Related]  

  • 56. What proportion of initially prescribed antidepressants is still being prescribed chronically after 5 years in general practice? A longitudinal cohort analysis.
    Verhaak PFM; de Beurs D; Spreeuwenberg P
    BMJ Open; 2019 Feb; 9(2):e024051. PubMed ID: 30813115
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The costs of prescribing in dispensing practices.
    Baines DL; Tolley KH; Whynes DK
    J Clin Pharm Ther; 1996 Oct; 21(5):343-8. PubMed ID: 9119917
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association of authorized generic marketing with prescription drug spending on antidepressants from 2000 to 2011.
    Cheng N; Banerjee T; Qian J; Hansen RA
    J Am Pharm Assoc (2003); 2017; 57(3):341-348. PubMed ID: 28400255
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prescriptions of antidepressants and anxiolytics in France 2012-2022 and changes with the COVID-19 pandemic: interrupted time series analysis.
    De Bandt D; Haile SR; Devillers L; Bourrion B; Menges D
    BMJ Ment Health; 2024 Feb; 27(1):. PubMed ID: 38413052
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antidepressant drug prescribing in Italy, 2000: analysis of a general practice database.
    Pietraru C; Barbui C; Poggio L; Tognoni G
    Eur J Clin Pharmacol; 2001 Oct; 57(8):605-9. PubMed ID: 11758640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.